Position in ANAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,067,101
-$90,639,406 QoQ
Shares Held
82,954
-97.1% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ANAB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,067,101 | 55,303 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $93,706,507 | 1,932,890 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $69,370,354 | 2,265,528 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $54,942,202 | 2,474,874 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $44,027,879 | 2,368,370 | Shares | Defined | 2025-07-21 | |
| 2025-02-14 | $35,890,913 | 1,691,372 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,815,697 | 54,200 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $448,574 | 17,900 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $19,459,488 | 864,100 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,890,633 | 788,545 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $14,209,912 | 791,200 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $29,694,549 | 1,459,909 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,581,842 | 1,681,147 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $65,828,958 | 2,124,200 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $64,443,488 | 2,526,200 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,291,497 | 851,800 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $32,597,358 | 1,317,600 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,935,801 | 257,145 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $16,346,411 | 760,300 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $4,711,182 | 210,886 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||